Tiantan Biological (600161)
SSE · 600161
Market Cap$25.5B
Revenue$6.2B
Employees5205
Listed OnSSE
Ticker600161
CEO / ExecMr. Yanlin He
HeadquartersBeijing
MarketMainland China
Websitewww.tiantanbio.com
Overview
Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and marketing of blood products in China and internationally. Its products include human serum albumin; intravenous human immunoglobulin; rabies immunoglobulin; tetanus immunoglobulin; hepatitis B immunoglobulin; freeze-dried intravenous hepatitis B human immunoglobulin; histamine human immunoglobulin; human prothrombin complex concentrate; lyophilized intravenous hepatitis B immunoglobulin;
Data Note
This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.